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Abstract— Human bone marrow mesenchymal stem cells (hBMSCs) comprise a cell population capable of self-renewal and 
multilineage differentiation commonly isolated from bone marrow aspirates of large bones. Their osteogenic potential has been 
extensively exploited for the biological evaluation of scaffolds or biomaterials with applications in bone tissue engineering. This 
work aimed to isolate hBMSCs from femoral heads of patients undergoing total hip arthroplasty and to evaluate their osteogenic 
potential. Briefly, the trabecular bone was extracted and mechanically disaggregated; the released cells were cultured and non-
adherent cells were removed after 4 days. The osteogenic potential was evaluated at the fifth passage after 14 and 20 days of 
induction, comparing cultures with and without osteogenic supplements, via Alizarin red staining and the quantification of the 
gene expression levels of the osteogenic markers collagen type I, osteonectin and bone sialoprotein through real-time RT-PCR. The 
obtained hBMSCs presented a stable undifferentiated phenotype after prolonged cell culture, matrix mineralization capabilities and 
expression of osteoblast phenotype upon osteogenic induction. The three markers were up-regulated in cultures under osteogenic 
conditions and 2 fold differences in their expression levels were found to be significant for the onset of the differentiation process. 
The obtained hBMSCs may have applications on the in vitro evaluation of the osteoinductivity of different biomaterials, bioactive 
molecules or tissue engineering scaffolds.
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Resumen— Las células madre mesenquimatosas de médula ósea humana (abreviadas hBMSCs) constituyen una fuente de células 
auto-renovables con alto potencial de diferenciación, comúnmente aisladas a partir de los aspirados medulares en huesos largos. Su 
diferenciación hacia el linaje osteogénico, por ejemplo, ha sido ampliamente utilizada para la evaluación biológica de biomateriales o 
matrices con aplicaciones en la ingeniería de tejidos óseos. El objetivo de este trabajo consistió en aislar hBMSCs a partir de la cabeza 
femoral de pacientes sometidos a artroplastia total de cadera, así como evaluar su potencial osteogénico. Brevemente, se extrajo el 
hueso esponjoso y se disgregó mecánicamente; las células desprendidas se cultivaron y las células no adherentes se eliminaron luego 
de 4 días. El potencial osteogénico se evaluó en la quinta generación de cultivo, mediante ensayos de diferenciación a 14 y 20 días 
donde se compararon cultivos con y sin suplementos osteogénicos. La evaluación se realizó mediante tinción con Alizarina Roja y la 
cuantificación de los niveles de expresión génica de los marcadores osteogénicos colágeno tipo I, osteonectinca y sialoprotiena ósea 
mediante RT-PCR en tiempo real. Las hBMSCs obtenidas presentaron un fenotipo no-diferenciado estable, así como la capacidad de 
mineralizar la matriz extracelular y expresar un fenotipo similar al osteoblasto durante la inducción osteogénica. Los tres marcadores 
evaluados se sobre-expresaron en los cultivos en condiciones osteogénicas, y se encontró que cambios hasta de 2X en sus niveles de 
expresión son relevantes para el desarrollo del proceso de diferenciación. El modelo de hBMSCS presentado podría ser utilizado para 
la evaluación in vitro de la osteoinductividad de diferentes biomateriales, moléculas bioactivas o matrices para ingeniería de tejidos. 
Palabras clave— Diferenciación celular, Células madre mesenquimatosas, Mineralización, Marcadores osteogénicos, Ingeniería 
de tejidos.
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I. IntroductIon
Mesenchymal stem cells obtained from human bone marrow (hBMSCs) have been widely studied 
because of their relative easy access and differentiation 
potential to the osteogenic, adipogenic and chondrogenic 
lineages, and other kind of tissues or cells, including 
hepatocytes, cardiomyocytes and neurons [1-2]. Their 
multipotentiality and self-renewal has increased the 
attention to this stem cell model as a self-renewing 
cell source with applications in tissue engineering and 
regenerative medicine [3-4]. Particularly, hBMSCs 
osteogenic potential has been extensively explored in 
the biological evaluation of bone tissue engineering 
scaffolding structures [5-7]. In addition, their isolation 
based on the adherence to the culture substrates 
constitutes a straightforward strategy for elimination of 
non-mensenchymal lineages, reducing the dependency 
on complex cell isolation methods which rely on the 
expression of specific surface markers [1, 8].
Although autologous transplantation of in vitro 
expanded stem cells, via direct cell implantation on 
the site of the lesion or using cell-loaded engineered 
scaffolds, holds great promise, the common strategies for 
cell harvesting require somehow traumatic procedures 
for aspirating the bone marrow [1, 6]. Therefore, in 
those studies where an autologous model is not required, 
it would be advantageous to work with a mesenchymal 
cell line displaying similar characteristics that could be 
isolated without inducing any trauma in the donor site 
or from tissues otherwise discarded in conventional 
surgical procedures. One example of such studies is the 
initial development and evaluation of new biomaterials 
or scaffolds, which may be tested and optimized in 
vitro prior to the in vivo studies that would require an 
autologous cell source [9-11]. Therefore, using a non-
autologous model would help to increase the availability 
of biological samples (e.g. donors) for experimentation as 
well as reduce the costs of these studies.
This work presents a method for the isolation of 
hBMSCs via processing of bone marrow and trabecular 
bone intermixtures from human femoral heads of patients 
undergoing total hip arthroplasty, and the subsequent 
characterization of their osteogenic potential by the 
assessment of calcium deposition on the extracellular 
matrix and the evaluation of the gene expression levels 
of osteogenic makers known to actively participate on the 
differentiation/mineralization process.
II. MaterIals and Methods
2.1 Human bone marrow mesenchymal stem cells 
isolation and culture
hBMSCs populations were extracted by the processing 
of the femoral head of three patients undergoing total hip 
arthroplasty, following a protocol previously described by 
the authors with some modifications [12]. The extraction 
protocol was approved by the Committees for Ethical 
Issues of the CES University and the Hospital Pablo 
Tobón Uribe and all samples were processed after written 
informed consent was obtained. The biological material 
used in this study would have been otherwise discarded 
during the standard surgical procedure. Briefly, under the 
sterile conditions of the operating room the femoral heads 
were segmented transversally into two hemispheres to 
expose the trabecular bone, which was later extracted with 
successive washes with phosphate buffered saline solution 
(PBS) (Gibco, USA) to facilitate the disaggregation of the 
tissue, and mechanically dissected to obtain fragments of 
approximately 2 mm3. The obtained solution from each 
hemisphere was recollected and filtered with a 70 μm cell 
strainer (Falcon, USA) before centrifuging at 400 g for 
10 min. Cell pellets were resuspended in non-osteogenic 
media (NO) consisting of Dulbecco’s modified Eagle’s 
Medium (DMEM) (Sigma, USA), supplemented with 
10% Fetal Bovine Serum (FBS) (Gibco, USA) and 1% 
Antibiotics (streptomycin and penicillin) (Gibco, USA), 
and cultured in 25 cm2 flasks at 37 °C in a humidified 
atmosphere containing 5% CO2. At day 4, the cultures were 
washed with PBS to remove the non-adherent cells and 
further expanded until ∼ 80% confluence, when they were 
harvested and expanded in 75 cm2 flasks. After subculture, 
these cells were designated as passage 1. In summary, the 
new protocol comprised two modifications: a reduction of 
the seeding area for the primary culture, with 50 cm2 for 
each hemisphere, and removal of the non-adherent cells 
4 days earlier in the cell culture history. The extracted 
hBMSCs were evaluated in terms of cell morphology and 
mineralization capability (qualitatively) but only cells 
from one donor at passage 5 were used to study the gene 
expression patterns of osteogenic markers. 
2.2 Differentiation to the osteogenic lineage
Osteogenic differentiation was evaluated at 14 and 
20 days post induction via Alizarin Red staining and 
quantitative RT-PCR (RT-qPCR), with triplicate cultures 
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for each method (Fig. 1). To induce the osteogenic 
differentiation of the hBMSCs, the cultures were 
maintained in osteogenic media (OM), consisting of NO 
supplemented with 0.2 mM ascorbic acid (Amresco, 
USA), 10 mM β-Glycerol Phosphate (Sigma, USA) and 
100 nM Dexamethasone (Sigma, USA) [7]. For each 
Fig. 1.  Schematic of the experimental design followed for the evaluation of the osteogenic potential of the hBMSCs. 14 and 20 day differentiation 
experiments, with and without osteogenic media, were evaluated via Alizarin Red S staining (ARS) and RT-qPCR. OM: Osteogenic media, 
NO: non-osteogenic media, CCM: cell culture medium, Q: RNA quantification.
2.3 Matrix mineralization
Alizarin Red S (ARS) stain was used to verify the state 
of osteogenic differentiation in terms of extracellular matrix 
mineralization [13]. Briefly, cells were fixed with 70% cold 
ethanol during 20 min, and then 500 µl of ARS (Sigma, 
USA) at 2% (W/V) pH 4.0 were added for 20 min. ARS 
solution was washed with ultra pure water and cultures were 
evaluated via phase contrast microscopy (Nikon Eclipse 
TS100, USA). The results were analyzed qualitatively based 
on the intensity of the staining and the extension of the 
ARS-stained positively areas (i.e. red spots).
2.4	 RNA	extraction	and	quantification
Total RNA was extracted using a spin-column based 
method and following the instructions of the manufacturer 
of the kit (RNeasy Mini Kit, Qiagen). Then, the extracted 
RNA was quantified using the Quant-iT RiboGreen Kit 
(Invitrogen, USA). The reactions were performed in a 
final volume of 100 μl by incubation in the real-time 
thermocylcer RotorGene 6000 (Corbett, Australia) for 2 
min at 25 °C followed by fluorescence acquisition at 25 °C. 
A 5 point calibration curve (100 μg/ml to 500 μg/ml) was 
experiment, 7x104 cells were seeded in 12 multi-well 
plates (Falcon, USA) for an estimated 80% confluence. 
Each experiment comprised 12 cultures, 6 under 
osteogenic conditions and 6 controls under normal 
cultures conditions (NO). Medium was changed every 
2-3 days. 
constructed using the standard RNA provided in the Kit, 
to transform fluorescence data into RNA concentration. All 
quantifications were performed in triplicate.
2.5 Quantitative RT-PCR (RT-qPCR)
A two step RT-PCR protocol was implemented for 
mRNA quantification. Briefly, 350ng of RNA were reverse 
transcribed using a QuantiTect Reverse Transcription 
Kit (Qiagen, USA) and following the instructions of the 
manufacturer. Reverse Transcription (RT) controls with 
no enzyme were prepared in order to detect potential 
contaminations with genomic DNA. cDNA and RT 
control samples were evaluated via quantitative PCR 
following the instructions of the manufacturer of the kit 
(QuantiTect SYBR Green, Qiagen). The reactions were 
performed with a final volume of 25 μl and using 300 nM 
for each primer (Table 1). The reactions were incubated 
in the real-time thermocycler RotorGene 6000 (Corbett, 
Australia). The PCR program consisted of an initial hold 
at 50°C for 2 min, followed by an activation step at 95°C 
for 15 min, and 45 cycles at 95°C for 15 sec, annealing 
at 60°C for 30 sec, and 72°C for 30 sec. Then, a melting 
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curve was constructed by heating from 65°C to 95°C with 
temperature steps of 0.4ºC. All reactions included 0.25 
U of uracil-DNA-glycosylase (Fermentas, USA) to 
avoid contamination with PCR products from previous 
reactions [14]. All quantifications were performed in 
duplicate. The analysis and estimation of the relative 
gene expression levels of the osteogenic markers was 
III. results
3.1 Cell differentiation and matrix mineralization
The hBMSCs cultures that were established from 
each of the three donors presented similar morphological 
and proliferation characteristics (proliferation data is 
not shown). After 2 days of the supplementation of the 
culture media the cells under osteogenic conditions 
exhibited morphological changes typical of the 
osteoblastic phenotype, and after 5 days the cells had 
acquired a polygonal osteoblast-like morphology (Fig. 
2A) [5]. Cells in non-osteogenic conditions maintained 
an undifferentiated phenotype with a fibroblast-like 
morphology (Fig. 2B). 
The results of the ARS staining of the 14 day 
differentiation assay are shown in Fig. 3. Matrix 
mineralization was not evident in the cultures under 
osteogenic conditions, with limited staining of small 
nodules in isolated regions (Fig. 3A), despite of the 
morphological changes indicative of the differentiation 
process that were observed in the first days of the 
osteogenic induction. However, the staining of the 
cultures of the 20 day differentiation experiment revealed 
an advanced process of calcium nodules formation 
characteristic of matrix mineralization (Fig. 4A-E). At 
both evaluation times, cultures under non-osteogenic 
conditions conserved the undifferentiated phenotype 
typical of these mesenchymal cells and did not present 
signs of matrix mineralization (Fig. 3B and Fig. 4F).
3.2 Expression of osteogenic markers
Gene expression levels of the osteogenic markers 
CI, ON and BSP under the different culture conditions 
evaluated in this study are shown in Fig. 5. The three 
osteogenic genes evaluated were up-regulated in 
the cultures under osteogenic conditions compared 
to the control cultures. However, when comparing 
the expression levels for each gene as a function of 
incubation time (i.e. OM20d vs. OM14d or NO20d 
vs. NO14d) no significant differences were found for 
CI (p=0.4314 for osteogenic cultures and p=0.103 for 
controls) and ON (p=0.1471 for osteogenic cultures 
and p=0.5465 for controls), but significance change 
was observed for BSP mRNA levels which were up-
regulated in the cultures with osteogenic media (OM20d 
vs. OM14d, p=0.0017) and down-regulated in cultures 
under non-osteogenic conditions (p<0.00001). The 
stability of the expression levels of the normalizer gene 
RPL13A was validated under the osteogenic conditions 
used in this study (data not shown). Finally, since the 
mathematical model used for mRNA quantification 
relies on the assumption that the amplification 
efficiencies are 100% (i.e. E=2), the reaction efficiencies 
were calculated based on single-reaction data [16]. The 
statistical analysis demonstrated that the assumption 
was valid for all the genes evaluated, since all the p-
values were above the significance level (p=0.05) as 
shown in Table 2. 
performed with the software qBase (i.e. the 2-∆∆CT 
method) using cultures under non-osteogenic conditions 
at day 14 as reference (calibrators) and RPL13A 
as housekeeping gene [15]. Statistical analysis was 
performed using STATGRAPHICS Software (Statistical 
Graphics Corp., Version 5), with an unstacked One-way 
ANOVA at a 95% confidence level.
Table 1. Primer sequences designed for all genes evaluated in this study: Ribosomal protein L13A (RPL13A), collagen type 
I alpha 1 (CI), osteonectin (ON) and bone sialoprotein II (BSP).
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Fig. 2. (A) Phase contrast microscopy images (10X) representative of 
the morphological changes induced after 5 days of culture in osteogenic 
media. (B) Control cultures showing an undifferentiated fibroblast-like 
morphology. 
Fig. 3. Alizarin Red staining for the 14 day differentiation assay. 
Cultures maintained with (A) or without (B) osteogenic media (20X). 
Extracellular matrix mineralization was not observed.
Fig. 4. Alizarin Red staining for the 20 day differentiation assay. (A-E) Matrix mineralization was evident in the form of calcium nodules (stained 
red) in the cultures under osteogenic conditions. (F) Control cultures presented no signs of mineralization. Magnification: A-D, F) 20X. E) 40X.
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Fig. 5. Gene expression levels of the osteogenic markers CI, ON 
and BSP, using RPL13A as normalizer gene, in cultures maintained 
for 14 and 20 days. OM14d/ NO14d: cultures under osteogenic/ 
non-osteogenic conditions during 14 days.
Table 2. Mean amplification efficiency (E) of the evaluated primer 
sets among all the reactions performed in this study. SD: standard 
deviation. P-value: result of a hypothesis test with null hypothesis E=2 
(alternative E<>2). 
Primer E SD P-value
Collagen Type I  2,00 0,06 0,952
Osteonectin 2,01 0,13 0,719
Bone Sialoprotein 2,02 0,14 0,441
RPL13A 1,99 0,10 0,677
IV. dIscussIon
The osteogenic potential of the isolated mesenchymal 
cells was confirmed with the qualitative analysis based 
on the staining of the calcium accumulated in the 
extracellular matrix, which is one of the main events 
in the osteogenic differentiation process [17]. The 
evaluation time points, 14 and 20 days, are representative 
of different stages of this process as observed on the extent 
of the matrix staining, although at both times the major 
morphological changes characteristic of the osteoblastic 
phenotype had already occurred. The observation of the 
major mineralization events after 20 days of culture (Fig. 
4) is in accordance with previous reports for mesenchymal 
stem cells suggesting similar osteogenic potentials [13, 
18]. The results also demonstrated that the hBMSCs 
extracted from the femoral heads are capable of triggering 
the matrix mineralization process even after 5 passages in 
standard culture conditions, a characteristic observed in 
other hBMSCs models [19]. This allows to obtain higher 
cell yields through in vitro expansion with a concomitant 
increase in culture homogeneity [13], which favors 
flexibility and reproducibility in the experimental designs 
of posterior studies.
The mesenchymal model here presented is capable 
of conserving a stable undifferentiated phenotype (i.e. 
spindle-shape, fibroblast-like phenotype) when cultured 
under normal conditions for up to 10 passages (as so far 
evaluated, data not shown) and, after prolonged culture 
at high confluence, neither morphological changes nor 
signs of matrix mineralization are observed (Fig. 2, 3, 4). 
In contrast, upon osteogenic induction with culture media 
conditioned with traditional osteogenic supplements 
the cultures acquire a marked polygonal osteoblast-like 
phenotype and mineralize their extracellular matrix. The 
possibility to obtain a population of cells with osteogenic 
potential with a stable undifferentiated phenotype 
is important for studies of osteogenic induction (i.e. 
osteogenic differentiation as a result of the interaction with 
different biomaterials, application of physical forces or 
exposure to bioactive molecules) [11, 20-22]. For instance, 
embryonic stem cells models with known multipotentiality 
and hence osteogenic potential may have drawbacks in that 
scenario due to their tendency to mineralize their matrix 
even without induction, although at a minor extent than 
when cultured in osteogenic conditions [23-24].
Although the hBMSCs model used in this study has 
basal expression levels of the osteogenic markers (Fig. 
5), only cultures under osteogenic conditions showed 
gene expression levels adequate for the induction of 
the osteogenic differentiation, as evidenced through the 
morphological changes and the mineralization of the 
extracellular matrix. In addition, the basal expression 
levels of these markers are important since they allow the 
use of relative quantification models of gene expression 
and therefore the precise quantification of the regulation of 
the osteogenic markers during the differentiation process 
as triggered by any treatment under evaluation [25].
The expression patterns of collagen type I, osteonectin 
and bone sialoprotein have been shown to be well-
correlated to the osteogenic differentiation process and 
are involved in the early and intermediate stages of matrix 
formation and mineralization [26-27]. In this study, the 
expression levels of the three markers were up-regulated in 
the cultures with osteogenic media when compared to the 
controls (Fig. 5). Collagen type I (alpha 1) upregulation 
(maximum fold increase of 5.4) is a prerequisite for 
osteogenic differentiation and matrix synthesis, since 
this protein comprises over 90% of the organic material 
in the bone matrix [28]. Similarly, osteonectin and bone 
sialoprotein are up-regulated during the initial phase of 
matrix mineralization, with BSP considered as the main 
nucleator of hydroxyapatite crystal formation [20, 29]. This 
important role is in accordance with its higher regulation 
during the differentiation process, since only BSP presented 
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statistically significant differences between cultures 
before and after mineralization (i.e. OM20d vs. OM14d). 
Moreover, correlation between the expression profiles 
of the ostegenic markers and the matrix mineralization 
process suggests that two fold or larger differences in the 
expression levels of these genes (Fig. 5) lead to phenotypic 
changes characteristic of the osteoblastic phenotype and 
to the onset of the mineralization process through bone 
nodule formation (Fig. 4).
A reduced number of studies have reported the 
extraction of BMSCs from the human femoral bone 
marrow. Most investigations with femoral heads have 
focused on trypsinization treatment of the trabecular 
bone or isolation of multipotent primary osteoblastic 
cells through explant cultures of trabecular bone [18, 
30]. In 2005, Schutze and collaborators demonstrated 
the possibility of isolating multipotential bone marrow-
derived mesenchymal stem cells from the processing 
of the trabecular bone in the femoral heads after 
repeated washings to release the cells from the bone 
plugs [31]. Pineda et al. 2007 reported the isolation of 
a cell population with mensenchymal characteristics 
using a variation of the mentioned protocol by means 
of mechanical disaggregation of the trabecular bone to 
release the cells from the femoral bone marrow [12]. In 
this study, this protocol was improved in terms of isolation 
efficiency through reduction of the surface culture area at 
the beginning of the primary culture (data not shown). In 
addition, the osteogenic potential of the cell population 
was verified demonstrating its capability of matrix 
mineralization upon osteogenic induction as well as the 
up-regulation in the gene expression levels of the evaluated 
osteogenic markers.
The isolated mesenchymal cells and the differentiation 
markers studied constitute an interesting model for the 
evaluation of the biological properties (e.g. osteoinductivity) 
of tissue engineering scaffolds and different biomaterials 
or bioactive molecules. The demonstrated stable 
undifferentiated phenotype in non-treated cultures is an 
interesting characteristic of the presented mensenchymal 
model, since it would allow the measurement of the 
osteoinductivity of different materials with independence 
of the phenotypic changes associated with culture time. 
Although mineralization studies with staining methods 
are simple and very informative, they can not be used 
often when the differentiation process takes place in a 
complex microenvironment (usually opaque), reducing the 
applicability of conventional optical imaging techniques 
or introducing non-specific staining in the system. For 
these reasons, the possibility of studying the differentiation 
process through the quantification of the expression levels 
of specific osteogenic markers turns out to be of high 
importance. Finally, the hBMSCs model presented in this 
study has limited applications on regenerative medicine 
or tissue repair due to the nature of the biological samples 
required for the isolation protocol.
V. conclusIon
The human bone marrow mensenchymal stem cells 
obtained in this study presented a stable undifferentiated 
phenotype under normal culture conditions after 
prolonged cell culture, and maintained their osteogenic 
potential after several passages as demonstrated by their 
capability to mineralize the extracellular matrix and the 
respective upregulation of the bone markers collagen 
type I, osteonectin and bone sialoprotein upon osteogenic 
induction after 5 passages. This hBMSCs extraction model 
presents several advantages compared to the bone marrow 
aspirates: 1) limited ethical issues for obtaining biological 
samples, 2) greater availability of tissue from total hip 
replacement surgeries, and 3) although not explored in 
this study, the possibility of also establishing osteoblast 
primary cultures from trabecular bone explants. The 
overall characteristics of the isolated stem cells, mainly 
their long-term osteogenic potential, stable undifferentiated 
phenotype, and basal expression levels of the studied 
osteogenic markers are desirable for in vitro evaluation 
of the osteoinductivity of different biomaterials, bioactive 
molecules or tissue engineering scaffolds.
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